About Curative Biotech
Curative Biotech is a company based in Boca Raton (United States) founded in 1995. Curative Biotech offers products and services including Drug Pipeline, Therapeutic Assets, and Neuro Oncology Drugs. Curative Biotech operates in a competitive market with competitors including EyePoint Pharmaceuticals, Rezolute, Molecular Partners, Imvax and Aviceda Therapeutics, among others.
- Headquarter Boca Raton, United States
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Curative Biotechnology Inc.
-
Annual Revenue
Not available
-
Net Profit
-$3.56 M (USD)9.91as on Dec 31, 2024
-
EBITDA
-$2.35 M (USD)-28as on Dec 31, 2024
-
Latest Funding Round
$146 K (USD), Post-IPO
Jan 17, 2023
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Curative Biotech
Curative Biotech is a publicly listed company on the OTC with ticker symbol CUBT in USA, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Curative Biotech
Curative Biotech offers a comprehensive portfolio of products and services, including Drug Pipeline, Therapeutic Assets, and Neuro Oncology Drugs.
Develops candidates for rare diseases like eye disorders
Targets infectious disease treatments through acquisition
Focuses on cancer-related drug candidates for rare indications
Funding Insights of Curative Biotech
Investments & Acquisitions by Curative Biotech
Investment portfolio details for Curative Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Curative Biotech
Detailed financials for Curative Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Curative Biotech Comparisons
Peer comparison for Curative Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Curative Biotech
Curative Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EyePoint Pharmaceuticals, Rezolute, Molecular Partners, Imvax and Aviceda Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Small molecule therapeutics for ophthalmic disorders are developed.
|
|
| Locked | Locked | Locked |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
|
| Locked | Locked | Locked |
Therapeutic solutions for diseases are developed using DARPin technology.
|
|
| Locked | Locked | Locked |
Patient-specific cell vaccines for glioma treatment are developed.
|
|
| Locked | Locked | Locked |
Biotherapeutics for glycol-immune diseases are developed across multiple therapeutic areas.
|
|
| Locked | Locked | Locked |
Gene therapy solutions for retinal diseases are developed.
|
Detailed competitors of Curative Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Curative Biotech
Complete news archive for Curative Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curative Biotech
Curative Biotech was founded in 1995 and raised its 1st funding round 28 years after it was founded.
Curative Biotech is headquartered in Boca Raton, United States. It is registered at Boca Raton, Florida, United States.
Curative Biotech was founded in 1995 in Boca Raton, United States, within the biotechnology sector. Focus is placed on developing therapeutic drugs targeting cancer, eye conditions, and infectious diseases. The pipeline includes candidates such as IMT504, an oligodeoxynucleotide for rabies treatment; CURB906, a fully humanized CD56 monoclonal antibody for brain tumors; and a reformulated metformin for degenerative eye disease. Operations center on drug candidate advancement for clinical applications.
Curative Biotech's top competitors include EyePoint Pharmaceuticals, Rezolute and Imvax.
Curative Biotech offers Drug Pipeline, Therapeutic Assets, and Neuro Oncology Drugs.
Yes, Curative Biotech is publicly traded on OTC under the ticker symbol CUBT.
The ticker symbol of Curative Biotech is CUBT on OTC.